These finding suggests that the presence of a high frequency of MMP9 macrophages in stroma may be used as a prognostic biomarker as cancer tissues with high infiltration of tumor-associated macrophages are associated with poor patient prognosis and resistance to therapies [41,42]. The gene discussed is MMP9; the disease is neoplasm.